Legislative Research: US HB8855 | 2019-2020 | 116th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2021-2022 117th Congress (Introduced - Dead) | To establish a program to address sickle cell disease and other heritable hemoglobinopathies. [HB8855 2021 Detail][HB8855 2021 Text][HB8855 2021 Comments] | 2022-09-16 Referred to the Subcommittee on Health. |
| 2019-2020 116th Congress (Introduced - Dead) | To prohibit Federal employees from making allegations or appeals with respect to an adverse action to more than one entity, and for other purposes. [HB8855 2019 Detail][HB8855 2019 Text][HB8855 2019 Comments] | 2020-12-03 Referred to the House Committee on Oversight and Reform. |
References Online
Legislative Citation
APA
US HB8855 | 2019-2020 | 116th Congress. (2020, December 03). LegiScan. Retrieved May 01, 2024, from https://legiscan.com/US/bill/HB8855/2019
MLA
"US HB8855 | 2019-2020 | 116th Congress." LegiScan. LegiScan LLC, 03 Dec. 2020. Web. 01 May. 2024. <https://legiscan.com/US/bill/HB8855/2019>.
Chicago
"US HB8855 | 2019-2020 | 116th Congress." December 03, 2020 LegiScan. Accessed May 01, 2024. https://legiscan.com/US/bill/HB8855/2019.
Turabian
LegiScan. US HB8855 | 2019-2020 | 116th Congress. 03 December 2020. https://legiscan.com/US/bill/HB8855/2019 (accessed May 01, 2024).
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/8855/all-info |
| Text | https://www.congress.gov/116/bills/hr8855/BILLS-116hr8855ih.pdf |
